USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACIL

Detalhes bibliográficos
Autor(a) principal: Ferrarin, Daniel Dantas
Data de Publicação: 2022
Outros Autores: Czeczko , Nicolau Gregori, Kubrusly , Luiz Fernando, Malafaia, Osvaldo, Sousa, Eros Luiz de, Repka, João Carlos Domingues, Caron, Pedro Henrique Lambach, Souza , Carlos José Franco de
Tipo de documento: preprint
Idioma: por
Título da fonte: SciELO Preprints
Texto Completo: https://preprints.scielo.org/index.php/scielo/preprint/view/4505
Resumo: Introduction: currently, the most relevant applications of perinatal derivatives are in wound healing, for example, the use of amniotic membrane (AM) as a biomaterials source for use in different healing processes. The anastomotic healing compromised by antimetabolic drugs, such as 5-fluorouracil (5-FU), is a potential target of AM. Objective: To evaluate the healing effects of the AM use in rats treated with 5-FU at a dose of 20 mg/kg on the 7th postoperative day, regarding the parameters percentage of type I collagen (mature), cell viability, microvascular density and granulation tissue formation. Method: Thirty-two Wistar rats were submitted to colotomy and colorraphy, separated in 4 groups with 8t rats each and received, by 7 days, different treatments intraperitoneally, once daily from the operation day until sacrifice: 1- saline solution (C), 2- 20 mg/kg 5-FU, 3- 20 mg/kg 5-FU and 4- MA, and MA. Results: Tthe treatment with 5-FU (20 mg/kg – 7 days) induced adverse effects in the anastomotic healing process evidenced by the decrease of type I collagen (mature), cell viability, percentage microvascular density, granulation tissue formation (leukocyte-fibrin crust and angio-fibroblastic proliferation). The use of AM, under these conditions, induced an improvement in type I collagen (mature) percentage. Conclusion: The treatment with 5-FU induced adverse effects on the healing anastomotic process, and the use of AM, under these conditions, induced improvement in type I (mature) collagen percentage.
id SCI-1_45a7586ee728c8913fbef84e1e35eba3
oai_identifier_str oai:ops.preprints.scielo.org:preprint/4505
network_acronym_str SCI-1
network_name_str SciELO Preprints
repository_id_str
spelling USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACILUSO DE MEMBRANA AMNIÓTICA HUMANA DESCELULARIZADA EM ANASTOMOSES INTESTINAIS: ESTUDO EM RATOS TRATADOS COM 5-FLUOROURACILMembrana amnióticaAnastomoseQuimioterapia antitumoralAmniotic membraneAnastomosisAntitumoral chemotherapyIntroduction: currently, the most relevant applications of perinatal derivatives are in wound healing, for example, the use of amniotic membrane (AM) as a biomaterials source for use in different healing processes. The anastomotic healing compromised by antimetabolic drugs, such as 5-fluorouracil (5-FU), is a potential target of AM. Objective: To evaluate the healing effects of the AM use in rats treated with 5-FU at a dose of 20 mg/kg on the 7th postoperative day, regarding the parameters percentage of type I collagen (mature), cell viability, microvascular density and granulation tissue formation. Method: Thirty-two Wistar rats were submitted to colotomy and colorraphy, separated in 4 groups with 8t rats each and received, by 7 days, different treatments intraperitoneally, once daily from the operation day until sacrifice: 1- saline solution (C), 2- 20 mg/kg 5-FU, 3- 20 mg/kg 5-FU and 4- MA, and MA. Results: Tthe treatment with 5-FU (20 mg/kg – 7 days) induced adverse effects in the anastomotic healing process evidenced by the decrease of type I collagen (mature), cell viability, percentage microvascular density, granulation tissue formation (leukocyte-fibrin crust and angio-fibroblastic proliferation). The use of AM, under these conditions, induced an improvement in type I collagen (mature) percentage. Conclusion: The treatment with 5-FU induced adverse effects on the healing anastomotic process, and the use of AM, under these conditions, induced improvement in type I (mature) collagen percentage.Introdução: Atualmente emerge em nosso meio aplicações mais relevantes dos derivados perinatais, por exemplo, a membrana amniótica (MA), como fonte de biomateriais para emprego em diferentes processos cicatriciais. O comprometimento anastomótico por drogas antimetabólicas como o 5-fluorouracil (5-FU) é um potencial alvo da MA. Objetivo: Avaliar os efeitos cicatriciais do uso da MA em ratos tratados com 5-FU na dose de 20 mg/kg ao 7º. dia de evolução pós-operatória quanto aos parâmetros porcentagem de colágeno tipo I (maduro), viabilidade celular, densidade microvascular e formação do tecido de granulação. Método: Utilizaram-se 32 ratos da linhagem Wistar submetidos à colotomia e colorrafia separados em 4 grupos com 8 e receberam diferentes tratamentos diariamente por via intraperitoneal até o dia do sacrifício: Solução fisiológica (C), 20  mg/kg 5-FU, 20 mg/kg 5-FU e MA, MA. Resultados: O tratamento com 20 mg/kg de 5-FU, ao 7º. dia pós-operatório induziu efeitos adversos no processo cicatricial anastomótico evidenciados pela diminuição da porcentagem de colágeno tipo I (maduro), da viabilidade celular, da densidade microvascular, da formação de crosta fibrinoleucocitária e da proliferação angiofibroblástica; o uso da MA nestas condições induziu melhora da porcentagem de colágeno tipo I (maduro). Conclusão: O tratamento com 20 mg/kg de 5-FU, ao 7º. dia pós-operatório induziu efeitos adversos no processo cicatricial anastomótico e o uso da MA nestas condições induziu melhora da porcentagem de colágeno tipo I (maduro).SciELO PreprintsSciELO PreprintsSciELO Preprints2022-07-27info:eu-repo/semantics/preprintinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://preprints.scielo.org/index.php/scielo/preprint/view/450510.1590/SciELOPreprints.4505porhttps://preprints.scielo.org/index.php/scielo/article/view/4505/8630Copyright (c) 2022 Daniel Dantas Ferrarin, Nicolau Gregori Czeczko , Luiz Fernando Kubrusly , Osvaldo Malafaia, Eros Luiz de Sousa, João Carlos Domingues Repka, Pedro Henrique Lambach Caron, Carlos José Franco de Souza https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessFerrarin, Daniel DantasCzeczko , Nicolau GregoriKubrusly , Luiz FernandoMalafaia, OsvaldoSousa, Eros Luiz deRepka, João Carlos DominguesCaron, Pedro Henrique LambachSouza , Carlos José Franco dereponame:SciELO Preprintsinstname:SciELOinstacron:SCI2022-07-27T15:04:43Zoai:ops.preprints.scielo.org:preprint/4505Servidor de preprintshttps://preprints.scielo.org/index.php/scieloONGhttps://preprints.scielo.org/index.php/scielo/oaiscielo.submission@scielo.orgopendoar:2022-07-27T15:04:43SciELO Preprints - SciELOfalse
dc.title.none.fl_str_mv USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACIL
USO DE MEMBRANA AMNIÓTICA HUMANA DESCELULARIZADA EM ANASTOMOSES INTESTINAIS: ESTUDO EM RATOS TRATADOS COM 5-FLUOROURACIL
title USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACIL
spellingShingle USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACIL
Ferrarin, Daniel Dantas
Membrana amniótica
Anastomose
Quimioterapia antitumoral
Amniotic membrane
Anastomosis
Antitumoral chemotherapy
title_short USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACIL
title_full USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACIL
title_fullStr USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACIL
title_full_unstemmed USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACIL
title_sort USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACIL
author Ferrarin, Daniel Dantas
author_facet Ferrarin, Daniel Dantas
Czeczko , Nicolau Gregori
Kubrusly , Luiz Fernando
Malafaia, Osvaldo
Sousa, Eros Luiz de
Repka, João Carlos Domingues
Caron, Pedro Henrique Lambach
Souza , Carlos José Franco de
author_role author
author2 Czeczko , Nicolau Gregori
Kubrusly , Luiz Fernando
Malafaia, Osvaldo
Sousa, Eros Luiz de
Repka, João Carlos Domingues
Caron, Pedro Henrique Lambach
Souza , Carlos José Franco de
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Ferrarin, Daniel Dantas
Czeczko , Nicolau Gregori
Kubrusly , Luiz Fernando
Malafaia, Osvaldo
Sousa, Eros Luiz de
Repka, João Carlos Domingues
Caron, Pedro Henrique Lambach
Souza , Carlos José Franco de
dc.subject.por.fl_str_mv Membrana amniótica
Anastomose
Quimioterapia antitumoral
Amniotic membrane
Anastomosis
Antitumoral chemotherapy
topic Membrana amniótica
Anastomose
Quimioterapia antitumoral
Amniotic membrane
Anastomosis
Antitumoral chemotherapy
description Introduction: currently, the most relevant applications of perinatal derivatives are in wound healing, for example, the use of amniotic membrane (AM) as a biomaterials source for use in different healing processes. The anastomotic healing compromised by antimetabolic drugs, such as 5-fluorouracil (5-FU), is a potential target of AM. Objective: To evaluate the healing effects of the AM use in rats treated with 5-FU at a dose of 20 mg/kg on the 7th postoperative day, regarding the parameters percentage of type I collagen (mature), cell viability, microvascular density and granulation tissue formation. Method: Thirty-two Wistar rats were submitted to colotomy and colorraphy, separated in 4 groups with 8t rats each and received, by 7 days, different treatments intraperitoneally, once daily from the operation day until sacrifice: 1- saline solution (C), 2- 20 mg/kg 5-FU, 3- 20 mg/kg 5-FU and 4- MA, and MA. Results: Tthe treatment with 5-FU (20 mg/kg – 7 days) induced adverse effects in the anastomotic healing process evidenced by the decrease of type I collagen (mature), cell viability, percentage microvascular density, granulation tissue formation (leukocyte-fibrin crust and angio-fibroblastic proliferation). The use of AM, under these conditions, induced an improvement in type I collagen (mature) percentage. Conclusion: The treatment with 5-FU induced adverse effects on the healing anastomotic process, and the use of AM, under these conditions, induced improvement in type I (mature) collagen percentage.
publishDate 2022
dc.date.none.fl_str_mv 2022-07-27
dc.type.driver.fl_str_mv info:eu-repo/semantics/preprint
info:eu-repo/semantics/publishedVersion
format preprint
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://preprints.scielo.org/index.php/scielo/preprint/view/4505
10.1590/SciELOPreprints.4505
url https://preprints.scielo.org/index.php/scielo/preprint/view/4505
identifier_str_mv 10.1590/SciELOPreprints.4505
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://preprints.scielo.org/index.php/scielo/article/view/4505/8630
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv SciELO Preprints
SciELO Preprints
SciELO Preprints
publisher.none.fl_str_mv SciELO Preprints
SciELO Preprints
SciELO Preprints
dc.source.none.fl_str_mv reponame:SciELO Preprints
instname:SciELO
instacron:SCI
instname_str SciELO
instacron_str SCI
institution SCI
reponame_str SciELO Preprints
collection SciELO Preprints
repository.name.fl_str_mv SciELO Preprints - SciELO
repository.mail.fl_str_mv scielo.submission@scielo.org
_version_ 1797047829223440384